Tirzepatide adds hepatoprotection to its armoury

Lancet Diabetes Endocrinol. 2022 Jun;10(6):374-375. doi: 10.1016/S2213-8587(22)00074-2. Epub 2022 Apr 22.

Author

Giovanni Targher¹

Affiliation

¹ Section of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona 37126, Italy. Electronic address: giovanni.targher@univr.it.

PMID: 35468320
DOI: 10.1016/S2213-8587(22)00074-2

No abstract available

Publication types

Comment

MeSH terms

Gastric Inhibitory Polypeptide*
Glucagon-Like Peptide-1 Receptor*
Humans

Substances

Glucagon-Like Peptide-1 Receptor
Gastric Inhibitory Polypeptide
tirzepatide